Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT06058442
Clinical Trial
The Pancreatic Enzymes After Gastrectomy Trial
Recruiting
Phase 3
View on ClinicalTrials.gov →
Summary
This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.
Protocol Amendment History
3 changes
notable
Trial sites expanded: 9 -> 12 locations
2026-08-13
notable
Primary completion pushed: 2027-06 -> 2028-02
2026-08-13
minor
Completion pushed: 2027-06 -> 2028-02
2026-08-13
Trial Details
NCT Number
NCT06058442
Lead Sponsor
University of Leipzig
Conditions
Gastrectomy
Enrollment
188 participants
Start Date
2024-01-24
Primary Completion
2028-02
(estimated)
Study Completion
2028-02
(estimated)
Updated on ClinicalTrials.gov
2026-08-12